UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Survival and desferrioxamine in thalassaemia major.

Modell, B; Letsky, EA; Flynn, DM; Peto, R; Weatherall, DJ; (1982) Survival and desferrioxamine in thalassaemia major. Br Med J (Clin Res Ed) , 284 (6322) pp. 1081-1084. 10.1136/bmj.284.6322.1081.

Full text not available from this repository.

Abstract

A small randomised trial and observation of all patients homozygous for beta-thalassaemia in Britain born in or before 1963 indicated that those patients who had received average weekly doses of more than 4 g of desferrioxamine over the previous few years were less likely to die in the near future than were patients of similar ages who had received less, or no, desferrioxamine.

Type: Article
Title: Survival and desferrioxamine in thalassaemia major.
Location: England
DOI: 10.1136/bmj.284.6322.1081
Keywords: Adolescent, Adult, Child, Child, Preschool, Clinical Trials as Topic, Deferoxamine, Dose-Response Relationship, Drug, Humans, Life Expectancy, Random Allocation, Thalassemia
UCL classification: UCL > Provost and Vice Provost Offices
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Pop Health Sciences > Institute of Epidemiology and Health
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Pop Health Sciences > Institute of Epidemiology and Health > Primary Care and Population Health
URI: http://discovery.ucl.ac.uk/id/eprint/1547858
Downloads since deposit
0Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item